Samuela Pegoraro
A5035372760- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Acute Ischemic Stroke Management
- Cardiac tumors and thrombi
- Lipoproteins and Cardiovascular Health
- Central Venous Catheters and Hemodialysis
- Sepsis Diagnosis and Treatment
- Diagnosis and Treatment of Venous Diseases
- Intracerebral and Subarachnoid Hemorrhage Research
- Health Systems, Economic Evaluations, Quality of Life
- Cerebrovascular and Carotid Artery Diseases
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
- Cerebral Venous Sinus Thrombosis
- Blood Coagulation and Thrombosis Mechanisms
University of Perugia
2024
University of Insubria
2016-2024
Azienda Socio Sanitaria Territoriale Lariana
2017
In patients with atrial fibrillation who suffered an ischemic stroke while on treatment nonvitamin K antagonist oral anticoagulants, rates and determinants of recurrent events major bleedings remain uncertain.This prospective multicenter observational study aimed to estimate the bleeding their in follow-up consecutive acute cerebrovascular event anticoagulant treatment. Afterwards, we compared estimated risks between whom therapy was changed those continued original treatment.After a mean...
Introduction: The efficacy and safety of statins for secondary prevention in patients who have experienced a cardioembolic stroke are not well-defined. However, previous observational data reported hyperlipidemia as risk factor both ischemic bleeding complications with AF stroke. Based on these premises, we conducted sub-analysis the RAF RAF-NOAC studies to evaluate acute AF. Materials methods: We combined patient from studies, prospective across Stroke Units Europe, United States, Asia...
Isolated distal deep vein thrombosis (IDDVT) is a common clinical manifestation of venous thromboembolism (VTE). However, there are only scant and heterogeneous data available on the long-term risk recurrent VTE after IDDVT, optimal therapeutic management remains uncertain. We carried out retrospective cohort study consecutive patients diagnosed with symptomatic IDDVT between 2004 2011, according to predefined short-term treatment protocol (low molecular weight heparin (LMWH) for 4–6 weeks)....
Introduction: Ischaemic stroke patients with atrial fibrillation (AF) are at high risk of recurrence despite oral anticoagulation therapy. Patients cardiovascular comorbidities may take both antiplatelet and therapy (OAC/AP). Our study aims to evaluate the safety efficacy OAC/AP as secondary prevention in people AF ischaemic stroke. methods: We performed a post-hoc analysis pooled individual data from multicenter prospective cohort studies compared outcomes on DOAC/VKA alone (OAC cohort)....
[Figure: see text].
Introduction: Patients with ischemic stroke (IS) and atrial fibrillation (AF) face a higher risk of recurrent vascular events. This study evaluates the impact atherosclerotic disease burden across different territories on events in patients recent AF within 90 days. Methods: We included IS from International RAF network prospective 90-day follow-up. Atherosclerotic was identified by at least one following: Symptomatic heart disease, symptomatic peripheral artery internal carotid stenosis...
Atrial fibrillation (AF) and congestive heart failure often coexist due to their shared risk factors leading potential worse outcome, particularly cerebrovascular events. The aims of this study were calculate the rates ischemic severe bleeding events in stroke patients having both AF reduced ejection fraction (rEF) (⩽40%), compared with but without rEF. We performed a retrospective analysis that drew data from prospective studies. primary outcome was composite either (stroke or systemic...
Abstract Background The efficacy and safety of statins for secondary prevention in patients who have experienced a cardioembolic stroke are not well-defined. However, previous observational data reported hyperlipidemia as risk factor both ischemic bleeding complications with AF stroke. Based on these premises, we conducted sub-analysis the RAF RAF-NOAC studies to evaluate acute AF. Methods We combined patient from studies, prospective across Stroke Units Europe, United States, Asia January...